BevanCJCreeBA. Disease activity free status: A new end point for a new era in multiple sclerosis clinical research?JAMA Neurol2014; 71: 269–270.
2.
GiovannoniGTurnerBGnanapavanS. Is it time to target no evident disease activity (NEDA) in multiple sclerosis?Mult Scler Relat Disord2015; 4: 329–333.
3.
DamascenoADamascenoBPCendesF. No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy. Mult Scler. Epub ahead of print 2October2015. DOI: 10.1177/1352458515604383.
4.
RotsteinDLHealyBCMalikMT. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort. JAMA Neurol2015; 72: 152–158.
5.
NygaardGOCeliusEGde Rodez BenaventSA. A longitudinal study of disability, cognition and gray matter atrophy in early multiple sclerosis patients according to evidence of disease activity. PLoS ONE2015; 10(8): e0135974.
